Publications by authors named "Matthew A Naylor"

Claim this Profile
H
Hypoxia-driven elimination of thiopurines from their nitrobenzyl prodrugs.
Peter Thomson, Matthew A Naylor, Michael R L Stratford, Gemma Lewis, Sally Hill

Bioorg Med Chem Lett· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological properties of bioreductively targeted nitrothienyl prodrugs of combretastatin A-4.
Peter Thomson, Matthew A Naylor, Steven A Everett, Michael R L Stratford, Gemma Lewis

Mol Cancer Ther· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancement of vascular targeting by inhibitors of nitric oxide synthase.
Peter D Davis, Gillian M Tozer, Matthew A Naylor, Peter Thomson, Gemma Lewis

Int J Radiat Oncol Biol Phys· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.
Peter D Davis, Graeme J Dougherty, David C Blakey, Susan M Galbraith, Gillian M Tozer, Matthew A Naylor

Cancer Res· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modifying rates of reductive elimination of leaving groups from indolequinone prodrugs: a key factor in controlling hypoxia-selective drug release.
Steven A Everett, Elizabeth Swann, Matthew A Naylor, Michael R L Stratford, Kantilal B Patel

Biochem Pharmacol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis